BioPorto

Research BioPorto (BIOPOR) on Bullrun: market cap DKK 547.10M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBIOPOR
• ExchangeCO
• CountryDenmark
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyDKK
• Market capDKK 547.10M
• Financial periodFY2025
• RevenueDKK 40.29M
• Revenue growth11.2%
• Net income-DKK 82.12M
• Free cash flow-DKK 77.07M
• Gross margin75.4%

Valuation Snapshot

latest market cap is DKK 547.10M.

About BioPorto

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI);

Frequently asked questions

What is BioPorto's market cap?

BioPorto's market capitalization is DKK 547.10M.

What does BioPorto do?

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia.